<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-75741</identifier>
<setSpec>0014-2565</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Therapeutic behavior to follow in the following clinical case: treatment of type 2 diabetes</dc:title>
<dc:description xml:lang="en">A 62-year old woman with obesity, high blood pressure and type 2 diabetes mellitus (DM2) was referred to a Vascular Risk Unit of the Internal Medicine Department due to elevated HbA1C (8.1%) in spite of having taken metformin (850mg/12h) and glipizide (10mg/12h) regularly. She tries to exercise daily (walking 30min) and has lost weight (from 5 to 12kg) several times, but always regains what she has lost. Furthermore, she monitors her glucose levels in fasting every two weeks and generally has between 120 and 160mg/dL. Her high blood pressure is being treated with enalapril/HCTZ and she also takes aspirin 100mg/day and simvastatin 20mg/day. It is seen in her family background that one brother died suddenly at 50 years of age. Her physical examination shows a BMI of 32.4Kg/m2, and she has no edemas in the lower limbs. Her BP is 154/82mmHg and creatinine 0.9mg/dL. She has no microalbuminuria and her liver function is normal.What treatment do you think would be the more appropriate?1 - Add glitazones.2 - Add incretin mimetics (GLP 1/ DPP-4).3 - Slow acting insulin(AU)</dc:description>
<dc:creator>Sánchez Rodríguez, A</dc:creator>
<dc:creator>Martin Oterino, J. A</dc:creator>
<dc:creator>Mateos, L</dc:creator>
<dc:creator>Herraez García, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Una mujer de 62 años con obesidad, hipertensión arterial y diabetes mellitus tipo 2 es remitida a una unidad de riesgo vascular del servicio de medicina interna porque su HbA1c está elevada (8,1%) a pesar de tomar regularmente metformina (850mg/12h) y glipizida (10mg/12h). Trata de hacer ejercicio cada día (caminar 30min) y ha adelgazado (de 5 a 12kg) en varias ocasiones, pero siempre ha vuelto a ganar lo perdido. Además se controla su glucemia en ayunas cada dos semanas y suele tener entre 120 y 160mg/dl. Su hipertensión arterial está siendo tratada con enalapril/HCTZ y además toma aspirina (100mg/día) y simvastatina (20mg/día). En su historia familiar se recoge que un hermano falleció súbitamente a los 50 años. En la exploración física presenta un IMC de 32,4kg/m2 y no tiene edemas en los MMII. Su PA es de 154/82mmHg y la creatinina de 0,9mg/dl. No presenta microalbuminuria y su función hepática es normal.¿Qué tratamiento le parece a Vd. más indicado?1. Añadir glitazonas.2. Añadir incretín miméticos (GLP1/inhibidores de la DPP-4).3. Añadir insulina de acción lenta(AU)</dc:description>
<dc:source>Rev Clin Esp;210(1): 23-27, ene.2010.</dc:source>
<dc:identifier>ibc-75741</dc:identifier>
<dc:title xml:lang="es">Conducta terapéutica a seguir en el siguiente caso clínico: tratamiento de la diabetes tipo 2</dc:title>
<dc:subject>^d3946^s22067</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d7005^s22073</dc:subject>
<dc:subject>^d28141</dc:subject>
<dc:subject>^d2359^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d2359^s22016</dc:subject>
<dc:subject>^d9951^s22012</dc:subject>
<dc:subject>^d23324^s22073</dc:subject>
<dc:subject>^d9951^s22016</dc:subject>
<dc:subject>^d7152^s22016</dc:subject>
<dc:subject>^d8862^s22073</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d6056^s22073</dc:subject>
<dc:subject>^d27951^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201001</dc:date>
</metadata>
</record>
</ibecs-document>
